Fabio Gallazzi Selected Research

tryptophylglycine

6/2012	Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.
11/2009	Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Gallazzi Research Topics

Disease

26	Neoplasms (Cancer) 02/2022 - 10/2002
20	Melanoma (Melanoma, Malignant) 02/2022 - 10/2002
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 04/2017
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 09/2011
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015 - 11/2003
2	Lymphoma (Lymphomas) 11/2015 - 11/2003
2	Alzheimer Disease (Alzheimer's Disease) 10/2011 - 02/2010
1	Cachexia 05/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	COVID-19 04/2021
1	Severe Acute Respiratory Syndrome 04/2021
1	Pain (Aches) 01/2019
1	Hypoxia (Hypoxemia) 01/2014
1	Amyloid Plaque 10/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2008
1	Disease Progression 11/2003
1	Leukemia 11/2003

Drug/Important Bio-Agent (IBA)

22	Peptides (Polypeptides)IBA 05/2022 - 10/2002
15	alpha-MSHIBA 02/2022 - 10/2002
12	Type 1 Melanocortin ReceptorIBA 02/2022 - 05/2009
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 11/2007
8	LactamsIBA 01/2017 - 02/2008
7	Melanocyte-Stimulating Hormones (MSH)IBA 01/2020 - 08/2009
6	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2021 - 07/2010
5	Chelating AgentsIBA 01/2017 - 11/2003
4	AcidsIBA 02/2022 - 04/2011
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 02/2018
4	Amino Acids FDA Link 11/2015 - 10/2002
4	N-glycylglutamic acidIBA 06/2012 - 02/2008
3	LigandsIBA 11/2019 - 01/2015
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2019 - 06/2012
3	Messenger RNA (mRNA)IBA 11/2015 - 11/2002
2	MelanocortinsIBA 05/2022 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
2	MetalsIBA 03/2021 - 05/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 03/2008
2	lysinenorleucineIBA 06/2012 - 11/2009
2	tryptophylglycineIBA 06/2012 - 11/2009
2	arginylprolineIBA 06/2012 - 11/2009
2	Lysine (L-Lysine)FDA Link 11/2007 - 10/2002
1	Pharmaceutical PreparationsIBA 05/2022
1	AlbuminsIBA 02/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	IntegrinsIBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2022
1	PeptidomimeticsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 04/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Lutetium-177IBA 01/2020
1	Cyclic PeptidesIBA 01/2020
1	AntigensIBA 11/2019
1	Coloring Agents (Dyes)IBA 11/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2018
1	cyanine dye 5IBA 02/2018
1	hexanoic acid (hexanoate)IBA 01/2017
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2017
1	CopperIBA 11/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2015
1	Tyr(3)- octreotateIBA 11/2015
1	EDDA (NiEDDA)IBA 01/2015
1	tricineIBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2014
1	1,2,4-benzotriazine 1,4-di-N-oxideIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	dioxotechnetiumIBA 01/2014
1	Copper-62IBA 10/2012
1	triazacyclononaneIBA 06/2012
1	Amyloid (Amyloid Fibrils)IBA 10/2011
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2011
1	Radioisotopes (Radionuclides)IBA 04/2011
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2010
1	Amyloid beta-PeptidesIBA 02/2010
1	arginyl-glycyl-aspartic acidIBA 08/2009
1	N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA 05/2009
1	N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA 05/2009
1	Bombesin Receptors (Bombesin Receptor)IBA 10/2008
1	BombesinIBA 10/2008
1	RheniumIBA 11/2007
1	1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA 01/2007
1	Codon (Codons)IBA 11/2003
1	Peptide Nucleic AcidsIBA 11/2003

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2002
4	Radiotherapy 01/2020 - 10/2002
1	Precision Medicine 01/2022
1	Computer-Assisted Surgery (Image Guided Surgery) 02/2018
1	Drug Therapy (Chemotherapy) 11/2003